DARK FOREST CAPITAL MANAGEMENT LP
Position in SMMT — Summit Therapeutics Inc.
CIK 1853322
NEW YORK, NY
Position in SMMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,549,353
+$2,017,765 QoQ
Shares Held
243,607
+201.6% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#51
of 242 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SMMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DARK FOREST CAPITAL MANAGEMENT LP holds $39,189,502 across 23 Biotechnology names. SMMT ranks #3 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
134,982 | $7,568,440 | |
| 2 | INCY |
Incyte Corp
|
37,331 | $4,231,842 | |
| 3 | SMMT |
Summit Therapeutics Inc.
This page
|
243,607 | $3,549,353 | |
| 4 | CYTK |
Cytokinetics Inc
|
36,708 | $3,127,154 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
28,982 | $2,519,984 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
38,420 | $2,113,100 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
209,163 | $1,831,222 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,547 | $1,588,156 |
All Filings in SMMT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,549,353 | 243,607 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,531,588 | 80,780 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,522,836 | 87,069 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,318,031 | 112,199 | Shares | Sole | 2025-11-17 | |
| 2025-03-31 | $1,804,540 | 93,548 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||